Navigation Links
Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
Date:11/4/2008

the first FDA-cleared diagnostic of its kind. PrognostiX' proprietary product pipeline includes valuable, high-margin cardiovascular and inflammatory biomarkers licensed to it exclusively by the Cleveland Clinic, the world's most respected cardiovascular center. Among these pipeline products is a novel biomarker that complements the cholesterol test, providing additional, more precise information for coronary artery disease risk assessment. The company also operates a CLIA-certified specialty reference laboratory, enabling it to bring promising new cardiovascular biomarkers to market more quickly. To learn more about PrognostiX, its product menu and pipeline, please visit http://www.prognostix.com.

Dr Hazen is lead investigator and a co-inventor of the Cleveland Clinic research team that discovered blood MPO levels serve as a diagnostic marker for cardiovascular disease risk and a monitor of responses to cardiac and anti-inflammatory therapies. Dr. Hazen is the scientific founder and paid consultant for PrognostiX Inc.

This press release may contain forward-looking statements within the meaning of the federal securities laws, including statements the potential benefits and impact of the CardioMPO Test. These statements reflect Inverness' current views with respect to future events and are based on management's current assumptions and information currently available. Actual results may differ materially due to numerous factors including, without limitation, risks associated with market acceptance of the product; the ability to successfully manufacture and distribute the product; the ability to secure and maintain the regulatory approvals or clearances necessary to sell the product in various markets; and the risks and uncertainties described in Inverness' annual report on Form 10-K, and other factors identified from time to time in its periodic filings with the Securities and Exchange Commission. Inv
'/>"/>

SOURCE Inverness Medical Innovations Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Inverness Medical Innovations to Present at the Third Annual JMP Securities Healthcare Focus Conference on October 7, 2008
2. Inverness Medical Innovations Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo
3. Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc.
4. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 24, 2008 to Discuss First Quarter 2008 Results
5. Correction: Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Inverness Medical Innovations, Inc.
6. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of Inverness Medical Innovations, Inc. Who Invested in the Inverness Medical Innovations, Inc. Employee Savings Plan
7. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 20, 2008 to Discuss Fourth Quarter 2007 Results
8. Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
9. Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
10. Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory
11. Inverness Medical Innovations to Participate at 2007 RBC Healthcare Conference on December 12, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... August 21, 2014 Living in a ... atmosphere that comes along with it. A quality Home ... that such amenities are available. , ... Fayetteville, Georgia and Community Association Management, LLC made a ... Parks Company to provide an additional amenity for their ...
(Date:8/21/2014)... the coronary arteries of chronic kidney disease patients may ... to a new study in the Journal of ... Researchers at the Johns Hopkins Bloomberg School of Public ... used measures of subclinical atherosclerosis in predicting the risk ... Approximately 50 percent of all patients with chronic kidney ...
(Date:8/21/2014)... 2014 Improv performers from Fun House ... dementia at Silverado Turtle Creek memory care community in ... entertainers ranging from ages 10 to 16, delivers a ... 40-minute set. The troupe's philosophy is that improv is ... them to touch audiences regardless of their circumstance — ...
(Date:8/21/2014)... 2014 The City of Garden Grove ... and programming for its inaugural “Re:Imagine Garden Grove – ... 2014, from 11 a.m. to 4 p.m., 2.85-miles of ... and the downtown will be filled with diverse music, ... Arts Resources (CARS), for all to enjoy. , The ...
(Date:8/21/2014)... seniors, dimming vision may be tied to poorer survival, new ... aged 65 to 84, who were assessed when they enrolled ... later. Vision loss over time was associated with an ... period, the researchers reported. Although the study couldn,t prove ... University in West Lafayette, Ind., offered up some theories on ...
Breaking Medicine News(10 mins):Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 3Health News:Measuring calcium buildup to predict heart disease in those with chronic kidney disease 2Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 3Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 4Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2
... medical practice of Acupuncture along with commonly used ... side effects of chemotherapy for breast cancer patients, ... are to be believed. , , ,According to ... electro-acupuncture was more effective in controlling vomiting than ...
... In what can be a watershed in cancer research, ... have used nuclear transfer technology to harvest life saving ... The same team had earlier cornered world wide fame ... Dolly – the world’s first cloned mammal: Using the ...
... In India Kidney Stones are not uncommon problem due to the ... up of Calcium, Oxalate and phosphates. The cause of stone disease ... water is a risk factor for stone disease. , ... is a tiny bacteria called Nano bacteria., ,These bacteria ...
... be responsible for a form of the herpes virus that ... sarcoma causes purple skin blotches and can also attack the ... normal disease defenses but attacks those with weakened immune system ... virus 8 was discovered six years ago. Almost 30% to ...
... cancer can effect men over the age of 40 years ... cancer. Usually it goes undetected till it is advanced and ... about this condition and now men over the age of ... ,One of the most promising "tumour markers" in medicine ...
... hormone replacement prescription drug, levothyroxine sodium (Unithroid) for hypothyroidism in ... the United States by the FDA. , ,The ... range of metabolic processes within the body in all age ... growth and intellectual development. , ,Low levels of thyroid ...
Cached Medicine News:
(Date:8/21/2014)...  Zacks.com announces the list of stocks featured in the ... the latest news and events impacting stocks and the financial ... HPQ - Free Report ), IBM (NYSE: IBM ... - Free Report ), GlaxoSmithKline plc (NYSE: GSK - ... - Free Report ). Today, Zacks is promoting ...
(Date:8/21/2014)...  ACI Clinical ( www.aciclinical.com ) announces a ... Using this solution, trial sponsors can ... costs and receive the same expertise that has ... Leveraging a decade of DMC experience ... statistical programming and meeting facilitation), ACI analyzed DMC ...
(Date:8/21/2014)... , Aug. 21, 2014 InfinityQS International, ... Manufacturing Intelligence , today announces Infusion Chicago, ... event will be held Oct. 9-10, 2014, at ... designed to showcase the necessity for implementing a ... and Manufacturing Intelligence to gain insight into production ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2
... SYDNEY, May 23, 2012 HeartWare International, Inc. (NASDAQ: ... of less invasive, miniaturized circulatory support technologies revolutionizing the ... has received an expanded European label for long-term use ... at risk of death from refractory, end-stage heart failure. ...
... ATLANTA, May 23, 2012   CryoLife, Inc. (NYSE: ... focused on cardiac and vascular surgery, announced today that ... Company, LLC One-on-One Investor Conference on Thursday, May 31, ... vice president, chief operating officer, and chief financial officer ...
Cached Medicine Technology:HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure 2HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure 3CryoLife to Participate in 3rd Annual Benchmark Company, LLC One-on-One Investor Conference 2
... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
Inquire...
250L...
250L...
Medicine Products: